CuraGen to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference

Friday, June 6, 2008 General News J E 4
BRANFORD, Conn., June 6 CuraGen Corporation(Nasdaq: CRGN) announced today that Dr. Timothy Shannon, President and ChiefExecutive Officer, will present at The Seventh Annual Needham & CompanyBiotechnology and Medical Technology Conference on Wednesday, June 11, 2008,at 3:30 p.m. Eastern time. The conference is being held at the New YorkPalace Hotel in New York, NY.

Access to a live webcast of the presentation will be available from theInvestor Relations section of CuraGen's website at Areplay of the webcast will be available after the presentation and archivedfor 30 days thereafter.

About CuraGen

CuraGen Corporation (Nasdaq: CRGN) is a clinical-stage biopharmaceuticalcompany developing promising approaches for the treatment of cancer. CuraGenCorporation is headquartered in Branford, Connecticut. For additionalinformation please visit Contact: Glenn Schulman, Pharm.D. Director Medical Communications (888) 436-6642 CRGN-G

SOURCE CuraGen Corporation


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Sangamo BioSciences Provides Update on Diabetic Ne...
Leading Academic Institutions Collaborate on 800-P...